Search Results - "Zhao, Zhongrun"

Preclinical evaluation of MRG002, a novel HER2-targeting antibody-drug conjugate with potent antitumor activity against HER2-positive solid tumors by Li, Hu, Zhang, Xiao, Xu, Zhenyi, Li, Lingrui, Liu, Wenchao, Dai, Zhenyu, Zhao, Zhongrun, Xiao, Lili, Li, Hongfeng, Hu, Chaohong

“…Abstract Background ERBB2 is a proto-oncogene of multiple cancers including breast and gastric cancers with HER2 protein overexpression or gene amplification…”
Get full text

Abstract 3124: MRG006A, a novel glypican-3-targeting antibody-drug conjugate, demonstrated potent anti-tumor activity and good safety profile in preclinical studies by Wang, Yanchun, Li, Hongfeng, Shen, Hao, Liu, Wenchao, Liu, Shoujia, Yin, Kequan, Xu, Haili, Cui, Xueyuan, Li, Wei, Liu, Wei, Wu, Xiangyu, Yang, Liu, Ma, Tian, Zhao, Zhongrun, Wang, Jun, Cui, Feifei, Fang, Lei, Qin, Minmin, Hu, Chaohong

“…Abstract Background: Hepatocellular carcinoma (HCC) is one of the most challenging cancers with high unmet medical need. Glypican-3 (GPC3) is an oncofetal…”
Get full text